SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to recent conditional marketing authorization for its bladder cancer drug Anktiva in Europe and Saudi FDA approvals, which the community sees as a catalyst for significant global expansion and broader application across various cancers. Investors are actively discussing the potential for a substantial short squeeze, driven by high short interest and belief in the drug's transformative impact on immunotherapy.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending after its recent earnings showed a significant EPS beat attributed largely to non-cash tax benefits, overshadowing an Adjusted EBITDA miss and fueling community concerns about "accounting magic" and opaque related-party dealings.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending as market participants debate how a proposed credit card interest rate cap could significantly benefit its merchant-funded, 0% interest buy-now-pay-later model, contrasting it sharply with traditional lenders. Despite its post-IPO struggles and current low valuation, many investors are highlighting Klarna's expanding partnerships and low default rates as reasons for a potential rebound.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending after its recent earnings presented mixed results, including revenue and net income misses, but strong order growth and a better-than-expected Marketplace GOV outlook sparked a dramatic price reversal. The community is actively debating whether the rally is a short squeeze or reflects underlying business strength.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is trending due to a significant partnership with the U.S. government and Brookfield to accelerate nuclear reactor deployment, a development seen by the community as vital for powering future AI growth and bolstering energy security. This initiative highlights Cameco's central role in the burgeoning nuclear energy renaissance and is driving widespread bullish sentiment despite some valuation concerns.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as the community eagerly awaits the February 21 PDUFA decision for Bysanti, which many view as a significant catalyst alongside the blockbuster potential of Tradipitant for GLP-1 induced nausea, fueling ongoing speculation of a major valuation re-rating or buyout despite recent dips.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as Cormorant Asset Management's significant re-purchase of shares at higher prices signals a potential institutional reversal of previous sentiment, fueling community speculation of further accumulation. Anticipation is high for the upcoming Investor Day, where new data on its "best-in-class" nanobody therapy for inflammatory diseases is expected to solidify its market position amid ongoing buyout rumors.

B2Gold Corp. is an exploration company, which engages in the acquisition and development of mineral properties. It operates through the following segments: Fekola Mine, Fekola Regional, Masbate Mine, Otjikoto Mine, Goose Project, Other Mineral Properties, and Corporate and Other. The Fekola Regional segment consists of Bantako North, Menankoto, Dandoko, and Bakolobi properties. The Other Mineral Properties segment focuses on the company interests in mineral properties which are at various stages of exploration and evaluation. The Corporate and Other segment includes the corporate operations. The company was founded by Mark Anthony Corra, Thomas A. Garagan, Clive Thomas Johnson, and Roger Thomas Richer on November 30, 2006 and is headquartered in Vancouver, Canada.

B2gold Corp

BTG is trending as its recent operational results and 2026 guidance ignite community debate, with many criticizing management's execution and higher All-In Sustaining Costs for the Goose mine, while a significant segment views the stock as deeply undervalued amidst the broader context of strong gold prices.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is a hot topic as an activist investor recently took a significant stake, coinciding with new CEO Michael Fiddelke implementing strategic changes focused on enhancing store experience and leveraging AI. The community is actively debating whether these initiatives will lead to a sustained turnaround for the retail giant.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending higher after strong earnings and an optimistic 2026 outlook, underscoring its dominance in the GLP-1 market against rivals like Novo Nordisk, while community discussions also highlight its strategic investments in manufacturing and pipeline diversification amid regulatory actions against compounded weight-loss drugs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSA Capital Partners LLP Trims Stake in SES AI Corporation $SES

GSA Capital Partners LLP decreased its holdings in shares of SES AI Corporation (NYSE:SES - Free Report) by 52.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...

SES AI Corporation (NYSE:SES) Sees Large Growth in Short Interest

SES AI Corporation (NYSE:SES - Get Free Report) saw a significant growth in short interest in January. As of January 30th, there was short interest totaling 11,905,719 shares, a growth of 21.7% from...

SES AI (NYSE:SES) Stock Price Up 10.7% - Here's What Happened

SES AI (NYSE:SES) Trading 10.7% Higher - Here's What Happened...

SES AI (NYSE:SES) Cut to Sell at Wall Street Zen

Wall Street Zen cut SES AI from a "hold" rating to a "sell" rating in a report on Saturday...

Universal Beteiligungs und Servicegesellschaft mbH Has $2.51 Million Position in SES AI Corporation $SES

Universal Beteiligungs und Servicegesellschaft mbH cut its stake in SES AI Corporation (NYSE:SES - Free Report) by 25.0% during the third quarter, according to its most recent disclosure with the...

SES AI Announces Date of Conference Call for Fourth Quarter 2025 Results

SES AI Corporation (SES AI) (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced it will release its 2025...

SES AI (NYSE:SES) Shares Down 6.4% - Here's What Happened

SES AI (NYSE:SES) Trading Down 6.4% - Here's Why...

SES AI (NYSE:SES) Shares Gap Up - Should You Buy?

SES AI (NYSE:SES) Shares Gap Up - Here's Why...

SES AI (NYSE:SES) Shares Up 8.1% - Here's What Happened

SES AI (NYSE:SES) Trading Up 8.1% - Time to Buy...

How Do Investors Really Feel About SES AI Corp?

SES AI Corp. engages in the development and production of high-performance Li-Metal rechargeable battery technology for electric vehicles (EVs) and other applications. SES is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms and recycling. The company was founded by Qichao Hu in 2012 and is headquartered in Woburn, MA.

SES AI Corporation - Ordinary Shares - Class A

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $WMT earnings on Thursday?

SES
SES AI Corporation - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SES News

SESSES AI Corporation - Ordinary Shares - Class A